{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:49:32Z","timestamp":1760233772324,"version":"build-2065373602"},"reference-count":41,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"HarmonicSS","award":["731944"],"award-info":[{"award-number":["731944"]}]},{"DOI":"10.13039\/501100003486","name":"Hellenic Rheumatology Society","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100003486","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Primary Sjogren\u2019s syndrome (SS) is an autoimmune disease with a strong predilection for lymphoma development, with earlier disease onset being postulated as an independent risk factor for this complication. Variations of the Leukocyte immunoglobulin-like receptor A3(LILRA3) gene have been previously shown to increase susceptibility for both SS and non-Hodgkin B-cell lymphoma (B-NHL) in the general population. We aimed to investigate whether variations of the LILRA3 gene could predispose for lymphoma development in the context of SS. Methods: Study population, all of Greek origin, included 101 SS cases with a current or previous diagnosis of lymphoma (SS-lymphoma, SS-L) and 301 primary SS patients not complicated by lymphoma (SS-non-lymphoma, SS-nL). All SS patients fulfilled the 2016 SS American College of Rheumatology\/European league against Rheumatism (ACR\/EULAR) classification criteria. A total of 381 healthy controls (HC) of similar age\/sex\/race distribution were also included. On the basis of the age of SS onset and the presence or absence of adverse predictors for lymphoma development, SS patients were further stratified into younger (\u226440 years) and older (&gt;40 years) age of disease onset, as well as into high\/medium and low risk groups. Polymerase chain reaction (PCR) was implemented for the detection of the following LILRA3 gene variants: homozygous non-deleted or functional wild type (+\/+) heterozygous (+\/\u2212) and homozygous deleted (\u2212\/\u2212). LILRA3 serum protein levels were quantitated by enzyme-linked immunosorbent assay (ELISA) in 85 individuals (29 SS-L, 35 SS-nL patients and 21 HC). Results: While no statistically significant differences were detected in the overall frequency of LILRA3 gene variants between SS-L, SS-nL and HC groups, LILRA3 serum protein levels were increased in the SS-L group compared to HC (1.27 \u00b1 1.34 vs. 0.38 \u00b1 0.34 ng\/mL, p-value: 0.004). After stratification according to the age of SS onset and history of lymphoma, as well as the presence or absence of adverse predictors for lymphoma development, the prevalence of the functional LILRA3 gene variant was found to be significantly increased in the young onset SS-L group compared to the HC of similar age and sex distribution (100% vs. 82.9%, p = 0.03), as well as in the high\/medium risk SS compared to the low risk SS (91.3 vs. 78.3%, p = 0.0012). Of note, young onset SS-L and SS-nL groups displayed higher LILRA3 serum levels compared to their older counterparts (p-values: 0.007 and 0.0005, respectively). Conclusion: The functional LILRA3 gene variant increases susceptibility to SS-related lymphoma development in patients with a disease onset of &lt;40 years old, implying that genetically determined deranged immune responses in younger SS individuals could underly their pronounced risk for lymphoma development.<\/jats:p>","DOI":"10.3390\/jcm10040644","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:49:26Z","timestamp":1613090966000},"page":"644","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren\u2019s Syndrome"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8099-8872","authenticated-orcid":false,"given":"Evangelia","family":"Argyriou","sequence":"first","affiliation":[{"name":"Department of Physiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Rheumatology Unit, Sismanogleio General Hospital, 15126 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianos","family":"Nezos","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Roussos","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-9193","authenticated-orcid":false,"given":"Aliki","family":"Venetsanopoulou","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Voulgarelis","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriaki","family":"Boki","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Sismanogleio General Hospital, 15126 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios G.","family":"Tzioufas","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Joint Academic Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haralampos M.","family":"Moutsopoulos","sequence":"additional","affiliation":[{"name":"Athens Academy, Chair Medical Sciences\/Immunology, 10679 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clio P.","family":"Mavragani","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Joint Academic Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of Primary Sj\u00f6gren\u2019s Syndrome: A Systematic Review and Meta-Analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"E579","DOI":"10.1503\/cmaj.122037","article-title":"Sj\u00f6gren Syndrome","volume":"186","author":"Mavragani","year":"2014","journal-title":"Can. Med. Assoc. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","article-title":"The Geoepidemiology of Sj\u00f6gren\u2019s Syndrome","volume":"9","author":"Mavragani","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical Evolution, and Morbidity and Mortality of Primary Sj\u00f6gren\u2019s Syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-Analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40674-020-00138-x","article-title":"Lymphoma in Sj\u00f6gren\u2019s Syndrome: Predictors and Therapeutic Options","volume":"6","author":"Skarlis","year":"2020","journal-title":"Curr. Treat. Options Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2018.08.007","article-title":"Lymphomagenesis in Sj\u00f6gren\u2019s Syndrome: Predictive Biomarkers towards Precision Medicine","volume":"18","author":"Goules","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102317","DOI":"10.1016\/j.jaut.2019.102317","article-title":"Genetic Contributors and Soluble Mediators in Prediction of Autoimmune Comorbidity","volume":"104","author":"Nezos","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/art.24804","article-title":"Association of Immunoglobulin-like Transcript 6 Deficiency with Sj\u00f6gren\u2019s Syndrome","volume":"60","author":"Kabalak","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Low, H.Z., Reuter, S., Topperwien, M., Dankenbrink, N., Peest, D., Kabalak, G., Stripecke, R., Schmidt, R.E., Matthias, T., and Witte, T. (2013). Association of the LILRA3 Deletion with B-NHL and Functional Characterization of the Immunostimulatory Molecule. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081360"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fimmu.2016.00281","article-title":"Leukocyte Ig-Like Receptors\u2014A Model for MHC Class I Disease Associations","volume":"7","author":"Hudson","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/eji.200838415","article-title":"LILRA5 Is Expressed by Synovial Tissue Macrophages in Rheumatoid Arthritis, Selectively Induces pro-Inflammatory Cytokines and IL-10 and Is Regulated by TNF-Alpha, IL-10 and IFN-Gamma","volume":"38","author":"Mitchell","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Brown, D.P., Jones, D.C., Anderson, K.J., Lapaque, N., Buerki, R.A., Trowsdale, J., and Allen, R.L. (2009). The Inhibitory Receptor LILRB4 (ILT3) Modulates Antigen Presenting Cell Phenotype and, along with LILRB2 (ILT4), Is Upregulated in Response to Salmonella Infection. BMC Immunol., 10.","DOI":"10.1186\/1471-2172-10-56"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1182\/blood-2007-05-089771","article-title":"The Inhibitory Receptor LILRB1 Modulates the Differentiation and Regulatory Potential of Human Dendritic Cells","volume":"111","author":"Young","year":"2008","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.0001-2815.2004.00290.x","article-title":"The LILR Family: Modulators of Innate and Adaptive Immune Pathways in Health and Disease","volume":"64","author":"Brown","year":"2004","journal-title":"Tissue Antigens"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/eji.200839080","article-title":"Alternative MRNA Splicing Creates Transcripts Encoding Soluble Proteins from Most LILR Genes","volume":"39","author":"Jones","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3899\/jrheum.091119","article-title":"Soluble LILRA3, a Potential Natural Antiinflammatory Protein, Is Increased in Patients with Rheumatoid Arthritis and Is Tightly Regulated by Interleukin 10, Tumor Necrosis Factor-Alpha, and Interferon-Gamma","volume":"37","author":"An","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1002\/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y","article-title":"Arrangement of the ILT Gene Cluster: A Common Null Allele of the ILT6 Gene Results from a 6.7-Kbp Deletion","volume":"30","author":"Torkar","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ajhg.2008.03.012","article-title":"Evidence for Natural Selection on Leukocyte Immunoglobulin-like Receptors for HLA Class I in Northeast Asians","volume":"82","author":"Hirayasu","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1136\/annrheumdis-2013-204441","article-title":"Impact of the Leucocyte Immunoglobulin-like Receptor A3 (LILRA3) on Susceptibility and Subphenotypes of Systemic Lupus Erythematosus and Sj\u00f6gren\u2019s Syndrome","volume":"74","author":"Du","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s10067-019-04624-z","article-title":"The Expression and Clinical Significance of Different Forms of LILRA3 in Systemic Lupus Erythematosus","volume":"38","author":"Du","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e3766","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the Risk for Lymphoma Development in Sjogren Syndrome: An Easy Tool for Clinical Use","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of Lymphoma in Sj\u00f6gren\u2019s Syndrome and Evaluation of the Lymphoma Risk in Prelymphomatous Conditions: Results of a Multicenter Study","volume":"51","author":"Quartuccio","year":"2014","journal-title":"J. Autoimmun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Nezos, A., Makri, P., Gandolfo, S., De Vita, S., Voulgarelis, M., Crow, M.K., and Mavragani, C.P. (2019). TREX1 Variants in Sjogren\u2019s Syndrome Related Lymphomagenesis. Cytokine, 154781.","DOI":"10.1016\/j.cyto.2019.154781"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/gene.2009.34","article-title":"Multiple Sclerosis Associates with LILRA3 Deletion in Spanish Patients","volume":"10","author":"Cisneros","year":"2009","journal-title":"Genes Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/art.39231","article-title":"A BAFF Receptor His159Tyr Mutation in Sj\u00f6gren\u2019s Syndrome-Related Lymphoproliferation","volume":"67","author":"Papageorgiou","year":"2015","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6923213","DOI":"10.1155\/2018\/6923213","article-title":"TNFAIP3 F127C Coding Variation in Greek Primary Sjogren\u2019s Syndrome Patients","volume":"2018","author":"Nezos","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"An, H., Lim, C., Guillemin, G.J., Vollmer-Conna, U., Rawlinson, W., Bryant, K., and Tedla, N. (2016). Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149200"},{"key":"ref_30","first-page":"689","article-title":"Juvenile Onset of Primary Sj\u00f6gren\u2019s Syndrome: Report of 10 Cases","volume":"14","author":"Ostuni","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/096120398678920019","article-title":"Young Onset of Primary Sj\u00f6gren\u2019s Syndrome: Clinical and Immunological Characteristics","volume":"7","author":"Cervera","year":"1998","journal-title":"Lupus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00431-003-1277-9","article-title":"Primary Sj\u00f6gren Syndrome in the Paediatric Age: A Multicentre Survey","volume":"162","author":"Cimaz","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s10067-017-3745-z","article-title":"A Systematic Review of Primary Sj\u00f6gren\u2019s Syndrome in Male and Paediatric Populations","volume":"36","author":"Virdee","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"594096","DOI":"10.3389\/fimmu.2020.594096","article-title":"Primary Sj\u00f6gren\u2019s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development","volume":"11","author":"Goules","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lawrence, T. (2009). The Nuclear Factor NF-\u039aB Pathway in Inflammation. Cold Spring Harb. Perspect. Biol., 1.","DOI":"10.1101\/cshperspect.a001651"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1136\/annrheumdis-2016-210788","article-title":"Multiomic Disease Signatures Converge to Cytotoxic CD8 T Cells in Primary Sj\u00f6gren\u2019s Syndrome","volume":"76","author":"Tasaki","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12977-016-0248-y","article-title":"TLR8 Regulation of LILRA3 in Monocytes Is Abrogated in Human Immunodeficiency Virus Infection and Correlates to CD4 Counts and Virus Loads","volume":"13","author":"Low","year":"2016","journal-title":"Retrovirology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/eji.200324323","article-title":"Expression Profiling of IL-10-Regulated Genes in Human Monocytes and Peripheral Blood Mononuclear Cells from Psoriatic Patients during IL-10 Therapy","volume":"34","author":"Jung","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.38308","article-title":"Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis","volume":"66","author":"Du","year":"2014","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3389\/fgene.2019.00869","article-title":"Frequencies of the LILRA3 6.7-Kb Deletion Are Highly Differentiated Among Han Chinese Subpopulations and Involved in Ankylosing Spondylitis Predisposition","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.gene.6364187","article-title":"Association of Multiple Sclerosis with ILT6 Deficiency","volume":"6","author":"Koch","year":"2005","journal-title":"Genes Immun."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/644\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:21:15Z","timestamp":1760160075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["jcm10040644"],"URL":"https:\/\/doi.org\/10.3390\/jcm10040644","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2021,2,8]]}}}